Comparative Relevance of Physical Fitness and Adiposity on Life Expectancy

Comparative Relevance of Physical Fitness and Adiposity on Life Expectancy

Comparative Relevance of Physical Fitness and Adiposity on Life Expectancy
A UK Biobank Observational Study
Francesco Zaccardi
Correspondence
Correspondence: Address to Francesco Zaccardi, MD, PhD, Leicester Diabetes Centre, Leicester General Hospital, Gwendolen Rd, Leicester LE5 4PW, United Kingdom.
Diabetes Research Centre, University of Leicester, United Kingdom
University Hospitals of Leicester NHS Trust, United Kingdom
Diabetes Research Centre, University of Leicester, United Kingdom
University Hospitals of Leicester NHS Trust, United Kingdom
NIHR Leicester Biomedical Research Centre, United Kingdom
Diabetes Research Centre, University of Leicester, United Kingdom
NIHR Collaborations for Leadership in Applied Health Research and Care (CLAHRC) East Midlands, United Kingdom
Diabetes Research Centre, University of Leicester, United Kingdom
NIHR Leicester Biomedical Research Centre, United Kingdom
Abstract
Objective
To investigate the extent to which 2 measures of physical fitness—walking pace and handgrip strength—are associated with life expectancy across different levels of adiposity, as the relative importance of physical fitness and adiposity on health outcomes is still debated.
Patients and Methods
Usual walking pace (self-defined as slow, steady/average, brisk), dynamometer-assessed handgrip strength, body mass index (BMI), waist circumference, and body-fat percentage determined at baseline in the UK Biobank prospective cohort study (March 13, 2006, to January 31, 2016). Life expectancy was estimated at 45 years of age.
Results
The median age and BMI of the 474,919 participants included in this analysis were 58.2 years and 26.7 kg/m2, respectively; over a median follow-up of 6.97 years, 12,823 deaths occurred. Participants reporting brisk walking pace had longer life expectancies across all levels of BMIs, ranging from 86.7 to 87.8 years in women and 85.2 to 86.8 years in men. Conversely, subjects reporting slow walking pace had shorter life expectancies, being the lowest observed in slow walkers with a BMI less than 20 kg/m2 (women: 72.4 years; men: 64.8 years). Smaller, less consistent differences in life expectancy were observed between participants with high and low handgrip strength, particularly in women. The same pattern of results was observed for waist circumference or body-fat percentage.
Conclusion
Brisk walkers were found to have longer life expectancies, which was constant across different levels and indices of adiposity. These findings could help clarify the relative importance of physical fitness and adiposity on mortality.
Abbreviations and Acronyms:
To read this article in full you will need to make a payment
Purchase one-time access:
For academic or personal research use, select 'Academic and Personal'
For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Fitness or fatness: which is more important?.
JAMA. 2018; 319: 231-232
Physical fitness and all-cause mortality: a prospective study of healthy men and women.
JAMA. 1989; 262: 2395-2401
The Joint Association of Fitness and Fatness on Cardiovascular Disease Mortality: a meta-analysis.
Prog Cardiovasc Dis. 2018; 61: 136-141
Migueles J.H.
et al.
Role of physical activity and fitness in the characterization and prognosis of the metabolically healthy obesity phenotype: a systematic review and meta-analysis.
Prog Cardiovasc Dis. 2018; 61: 190-205
Sustained physical activity, not weight loss, associated with improved survival in coronary heart disease.
J Am Coll Cardiol. 2018; 71: 1094-1101
Survival of the fittest: promoting fitness throughout the life span.
Mayo Clin Proc. 2017; 92: 1743-1745
Healthy weight and obesity prevention: JACC Health Promotion Series.
J Am Coll Cardiol. 2018; 72: 1506-1531
Promoting physical activity and exercise: JACC Health Promotion Series.
J Am Coll Cardiol. 2018; 72: 1622-1639
Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women.
J Gerontol A Biol Sci Med Sci. 2002; 57: M772-M777
Incidence and predictors of sarcopenia onset in community-dwelling elderly Japanese women: 4-year follow-up study.
J Am Med Dir Assoc. 2015; 16: 85.e1-85.e8
Prasad M.
et al.
BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants.
BMJ. 2016; 353: i2156
Estimating the treatment effect in a clinical trial using difference in restricted mean survival time.
Stata J. 2015; 15: 1098-1117
Royston P.
Hackshaw A.
Life expectancy difference and life expectancy ratio: two measures of treatment effects in randomised trials with non-proportional hazards.
BMJ. 2017; 357: j2250
The hazards of hazard ratios.
Epidemiology. 2010; 21: 13-15
Flexible Parametric Survival Analysis Using Stata: Beyond the Cox Model.
Stata Press, College Station, TX2011
Gyntelberg F.
et al.
Self-reported cardiorespiratory fitness: prediction and classification of risk of cardiovascular disease mortality and longevity: a prospective investigation in the Copenhagen City Heart Study.
J Am Heart Assoc. 2015; 4: e001495
Years of life gained due to leisure-time physical activity in the U.S.
Am J Prev Med. 2013; 44: 23-29
Matthews C.E.
et al.
Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis.
PLoS Med. 2012; 9: e1001335
Individual and aggregate years-of-life-lost associated with overweight and obesity.
Obesity (Silver Spring). 2010; 18: 333-339
Years of life lost due to obesity.
JAMA. 2003; 289: 187-193
Peto J.
Babiker A.G.
Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group.
Stat Med. 1991; 10: 1025-1035
Improved estimates of floating absolute risk.
Stat Med. 2004; 23: 93-104
National Institutes of Health
Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report.
Obesity Res. 1998; 6: S51-S209
Epi: a package for statistical analysis in epidemiology version 2.30.
R Package Version. 2008; 1
Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study.
Lancet. 2015; 386: 266-273
Tanaka S.
et al.
Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis.
JAMA. 2009; 301: 2024-2035
Objectively measured physical capability levels and mortality: systematic review and meta-analysis.
BMJ. 2010; 341: c4467
Dhalwani N.N.
et al.
Association of walking pace and handgrip strength with all-cause, cardiovascular, and cancer mortality: a UK Biobank observational study.
Eur Heart J. 2017; 38: 3232-3240
Blair S.N.
Lee I.M.
A history of physical activity, cardiovascular health and longevity: the scientific contributions of Jeremy N. Morris, DSc, DPH, FRCP.
Int J Epidemiol. 2001; 30: 1184-1192
Prina M.
et al.
Frailty and the prediction of dependence and mortality in low- and middle-income countries: a 10/66 population-based cohort study.
BMC Med. 2015; 13: 138
Self-reported walking speed: a useful marker of physical performance among community-dwelling older people?.
J Am Med Dir Assoc. 2015; 16: 323-328
Physical activity versus cardiorespiratory fitness: two (partly) distinct components of cardiovascular health?.
Prog Cardiovasc Dis. 2015; 57: 324-329
A meta-analysis but not a systematic review: an evaluation of the Global BMI Mortality Collaboration.
J Clin Epidemiol. 2017; 88: 21-29
Orpana H.
Graubard B.I.
Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis.
JAMA. 2013; 309: 71-82
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents.
Lancet. 2016; 388: 776-786
Patel K.V.
Lavie C.J.
Obesity, central adiposity, and fitness: understanding the obesity paradox in the context of other cardiometabolic parameters.
Mayo Clin Proc. 2018; 93: 676-678
Obesity and heart failure: focus on the obesity paradox.
Mayo Clin Proc. 2017; 92: 266-279
Lemieux I.
Despres J.P.
Overview of epidemiology and contribution of obesity and body fat distribution to cardiovascular disease: an update.
Prog Cardiovasc Dis. 2018; 61: 103-113
Published online: May 09, 2019
Footnotes
For editorial comment, see page 942
Grant Support: Drs Davies and Yates received funding from National Institute for Health Research (NIHR), Leicester Biomedical Research Centre , Leicester, UK. Dr Khunti received funding from NIHR Collaboration for Leadership in Applied Health Research and Care, East Midlands. Dr Zaccardi is a clinical research fellow, funded with an unrestricted educational grant from the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (CLAHRC), East Midlands to the University of Leicester; the funding source had no role in study design, data collection, data analysis, data interpretation or writing of the report. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.
Potential Competing Interests: Dr Khunti is on speaker bureaus for Novartis, Novo Nordisk, Sanofi-Aventis, Lilly, Servier, and Merck Sharp & Dohme. He has received grants in support of investigator and investigator-initiated trials from Novartis , Novo Nordisk , Sanofi-Aventis , Lilly , Pfizer , Boehringer Ingelheim , and Merck Sharp & Dohme and funds for research and honoraria for speaking at meetings and advisory boards for Lilly, Sanofi-Aventis, Merck Sharp & Dohme, and Novo Nordisk. Dr Davies is a consultant, advisory board member, and speaker for Novo Nordisk, Sanofi-Aventis, Lilly, Merck Sharp & Dohme, Boehringer Ingelheim, AstraZeneca, and Janssen and speaker for Mitsubishi Tanabe Pharma Corporation. She has received grants in support of investigator and investigator-initiated trials from Novo Nordisk , Sanofi-Aventis , and Lilly . Drs Zaccardi and Yates have no potential competing interests to report.
Publication dates: Received for publication September 13, 2018; revisions received October 24, 2018; accepted for publication October 31, 2018.
Identification

Images Powered by Shutterstock